Clinical Trials Logo

Filter by:
NCT ID: NCT03949673 Terminated - Clinical trials for Osteoarthritis, Knee

Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip

Start date: April 8, 2019
Phase: Phase 2
Study type: Interventional

The objective of this exploratory study is to evaluate the cellular and connective tissue composition of joints from patients with Osteoarthritis (OA) who have been treated with fasinumab, compared with those treated with placebo or Non-steroidal anti-inflammatory drugs (NSAIDs).

NCT ID: NCT03949491 Terminated - Clinical trials for Breast Reconstruction

Free Flap Breast Reconstruction Using Virtual Surgical Planning and 3-D Modeling

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if 3D modeling and Virtual Planning Surgery can improve the clinical outcome with patient who have a mastectomy requiring breast reconstruction.

NCT ID: NCT03949023 Terminated - Cerebral Angiogram Clinical Trials

Influence of Contrast Injection Force on the Accuracy of Vessel Measurements in Cerebral Angiography

Start date: July 12, 2018
Phase:
Study type: Observational

The purpose of this research study is to collect data/measurements that are routinely collected in standard of care cerebral angiogram

NCT ID: NCT03948334 Terminated - Atopic Dermatitis Clinical Trials

A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients

ZESTExt
Start date: April 4, 2019
Phase: Phase 2
Study type: Interventional

This extension study (CZPL389A2203E1) was designed as a 2-year (100 weeks) extension to the core study (CZPL389A2203/ NCT03517566) which is disclosed separately. It aimed to assess the short-term and long-term safety of (blinded) 30 mg o.d and 50 mg o.d ZPL389 with concomitant or intermittent use of topical corticosteroids (TCS) and/or topical calcineurin inhibitors (TCI).

NCT ID: NCT03948178 Terminated - Clinical trials for Amyotrophic Lateral Sclerosis

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

REFALS-ES
Start date: June 26, 2019
Phase: Phase 3
Study type: Interventional

This study provides an opportunity for subjects in the REFALS (3119002; NCT03505021) study to continue treatment with oral levosimendan. The study will also provide more information about long-term safety and effectiveness of oral levosimendan in patients with ALS. This is an open-label study, so that all eligible subjects that complete the double-blind REFALS study (48-weeks of treatment) will have the opportunity to receive oral levosimendan treatment. The primary objective, in addition to continuing treatment for subjects enrolled in the REFALS study, is to evaluate long-term safety of oral levosimendan in ALS patients. Another important objective is to explore long-term effectiveness of oral levosimendan in the treatment of patients with ALS. This study is open only to patients taking part in the REFALS study.

NCT ID: NCT03947918 Terminated - Sleep Clinical Trials

Summertime: Kids in Motion

Start date: June 17, 2019
Phase: N/A
Study type: Interventional

This is a 3-week randomized crossover study to determine the effect of the prior night's sleep duration on energy-balance related behaviors of diet and physical activity the following day. In Week 1, child participants will sleep their usual amount. In week 2, participants will be randomized to either a sleep restricted or a healthy sleep condition for 4 nights. In week 3, participants will cross over to the opposite sleep condition for 4 nights.

NCT ID: NCT03947281 Terminated - Obesity Clinical Trials

Snacks and Satiety

Start date: June 24, 2019
Phase: N/A
Study type: Interventional

This study is designed to compare two types of snacks (almonds or a cereal-based snack), eaten between meals, on measures of appetite, including appetitive hormones, self-reported feelings of hunger and fullness, and food intake at a buffet meal or in the home environment. The investigators hypothesize that the acute responses of appetitive hormones to a meal challenge protocol will differ between almond and cereal-based snacks based on multivariate models of satiety that will be predictive of ad libitum food intake at a dinner meal as part of the meal challenge protocol. Further, the investigators will estimate if, under free-living conditions, self-selected and self-reported food intake will show appropriate energy compensation for the added calories of the snacks, and determine if one type of snack is superior to the other in this regard.

NCT ID: NCT03947255 Terminated - Hodgkin Lymphoma Clinical Trials

A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma

Start date: October 28, 2019
Phase: Phase 2
Study type: Interventional

This study will look at whether brentuximab vedotin works and is safe in the re-treatment setting. To be in this study, patients must have already received brentuximab vedotin as treatment and have cancer that progressed (got worse) after stopping treatment.

NCT ID: NCT03946709 Terminated - Sarcopenia Clinical Trials

Mirror Neurons in Older Participants

MNOP
Start date: December 20, 2018
Phase: N/A
Study type: Interventional

A critical problem facing aging adults is muscle weakness. Whereas scientists have traditionally attributed the loss of muscle strength with aging to muscle atrophy, emerging evidence suggests that impairments in the neuromuscular system's ability to voluntarily generate force plays a more central role than previously appreciated. One area that has not yet been investigated includes the role that observing another's actions - thereby activating mirror neurons - plays in muscle force generation. Therefore, the purpose of this study is to examine the acute effects of action observation on muscular strength, voluntary muscle activation, and cortical excitability and inhibition in older adults.

NCT ID: NCT03946631 Terminated - Clinical trials for Diabetes Mellitus, Type 2

GDM Post Partum Screening

Start date: August 20, 2019
Phase:
Study type: Observational

Immediate postpartum screening for diabetes mellitus in women with gestational diabetes The objective of this study is to determine if screening for type 2 diabetes can be done 24 hours after delivery, versus 6-12 weeks postpartum, in recently delivered women having been diagnosed with gestational diabetes requiring medication therapy in the antecedent pregnancy.